The Baloxavir Marboxil Tablet, cataloged under National Stock Number 6505-01-693-3211, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Genentech Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-693-3211 |
| Primary Part Number | NDC50242-0860-02 |
| Item Name | Baloxavir Marboxil Tablet |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Genentech Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC50242-0860-02 PRIMARY | Genentech Inc (USA) |
| Reference | Meaning |
|---|---|
| XOFUZA | 5/1 Secondary reference Genentech Inc |
| 1589932 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM216842 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-693-3211 is a Baloxavir Marboxil Tablet, manufactured by Genentech Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-693-3211 has 1 manufacturer part number on file: NDC50242-0860-02 (Genentech Inc).
Key specifications for NDC50242-0860-02: Special Features: IS A POLYMERASE ACIDIC (PA) ENDONUCLEASE INHIBITOR INDICATED FOR THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA IN PATIENTS 12 YEARS OF AGE AND OLDER; TAKE A SINGLE DOSE OF XOFLUZA ORALLY WITHIN 48 HOURS OF SYMPTOMS ONSET; AVOID CO-ADMINISTRATION WITH POLYVALENT CATION-CONTAINING LAXATIVES, ANTACIDS, OR ORAL SUPPLEMENTS; ONE ADULT DOSE OF TWO 40 MG TABLETS COME IN BLISTER PACK; STORE XOFLUZA IN ITS BLISTER PACKAGE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED TO 15 C TO 30 C (59 F TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE).; Part Name Assigned by Controlling Agency: BALOXAVIR MARBOXIL TABLET, 40MG, 2S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.